K
KNSA
Kiniksa Pharmaceuticals Internat…
46.85
-0.45-0.95%Opening10:18 04/14 EDT
OPEN/PREV CLOSE47.13/47.30
TODAY RANGE46.56-47.78
VOL46.78K
MARKET CAP3.59B
52 WEEK RANGE19.41-50.03
AVG VOL (3M)632.18K
% TURNOVER0.06%
TURNOVER--
P/E (TTM)62.71
% RANGE2.58%
EPS(TTM)0.7471
P/E(FORWARD)40.96
P/B6.30
BVPS7.44
DIVIDEND--
P/S5.28
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.07B
SHARES OUTSTANDING76.54M
NEXT EARNINGS04/21-05/02
FREE FLOAT44.19M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·2d ago
A Look At Kiniksa Pharmaceuticals (KNSA) Valuation As Heart’s Home Campaign Targets ARCALYST Growth
Simply Wall St·5d ago
Kiniksa’s Heart’s Home Campaign Targets ARCALYST Growth In Pericarditis Market
TipRanks·6d ago
Kiniksa launches direct-to-consumer campaign for Arcalyst
Simply Wall St·04/04 20:26
Assessing Kiniksa Pharmaceuticals (KNSA) Valuation As Earnings Growth Supports Profitability And Shares Trade Near 52 Week High
TipRanks·03/11 00:23
Kiniksa Pharmaceuticals Earnings Call Highlights ARCALYST Surge
Simply Wall St·03/06 21:24
A Look At Kiniksa Pharmaceuticals International’s Valuation After Strong 2025 Growth And ARCALYST Commercial Momentum
Reuters·03/04 21:41
Kiniksa Pharmaceuticals CMO John F. Paolini Disposes of Common Shares
Simply Wall St·03/04 16:29
How Investors Are Reacting To Kiniksa (KNSA) Turning ARCALYST Revenue Into Full-Year Profitability And Flexibility
Same Industry
Name/Symbol
Change%
Price